Meeting Coverage

At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”

At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”

At the 2023 NACLC, Florian Fintelman, MD, presented a recap of data on the use of artificial intelligence for lung cancer risk prediction on chest CT.

Forget the O’Hare food kiosks and grab lunch at one of these locations instead, all within easy walking distance from the Chicago Marriott Downtown Magnificent Mile

Don’t miss the 2023 NACLC closing keynote—Perioperative Therapy—to be given by Jonathan Spicer, MD, PhD, 11:15 a.m.-12:15 p.m., Sunday, December 3, 2023.

Make the most of your final day at the 2023 NACLC conference—use the program information below to plan your schedule:

Many barriers exist in the recruitment for diabetic macular edema clinical trials of patients of minority racial and ethnic backgrounds.

2023 NACLC is taking place in Chicago’s famous “Magnificent Mile” district, so be sure to set aside a little time for exploring!

Check out the fascinating array of topics to be covered during 2023 NACLC satellite CME symposia!

The IASLC 2023 North America Conference on Lung Cancer (NACLC) runs December 1-3, 2023, at the...

Aflibercept 8 mg shows efficacy for patients with diabetic macular edema regardless of sex, age, and race/ethnicity.